Silva, Daniel-Adriano
Yu, Shawn
Ulge, Umut Y.
Spangler, Jamie B.
Jude, Kevin M.
Labão-Almeida, Carlos
Ali, Lestat R.
Quijano-Rubio, Alfredo
Ruterbusch, Mikel
Leung, Isabel
Biary, Tamara
Crowley, Stephanie J.
Marcos, Enrique
Walkey, Carl D.
Weitzner, Brian D.
Pardo-Avila, Fátima
Castellanos, Javier
Carter, Lauren
Stewart, Lance
Riddell, Stanley R.
Pepper, Marion
Bernardes, Gonçalo J. L.
Dougan, Michael
Garcia, K. Christopher
Baker, David
Article History
Received: 1 June 2018
Accepted: 15 November 2018
First Online: 9 January 2019
Competing interests
: D.-A.S., S.Y., U.Y.U., A.Q.-R., C.D.W. and D.B. are co-founders and stockholders of Neoleukin Therapeutics, a company that aims to develop the inventions described in this manuscript. D.-A.S., S.Y., U.Y.U., J.B.S., A.Q.-R., K.C.G. and D.B. are co-inventors on a US provisional patent application (no. 62/689769), which incorporates discoveries described in this manuscript.